Strategic partnerships are an integral component of Acella Pharmaceutical’s growth strategy. We value collaboration, and are focused on developing and building upon robust relationships and alliances.
Among our growth strategy initiatives:
We seek to partner with major U.S. purchasers of pharmaceuticals to create awareness and make available niche, low-profile medications to patients.
We endeavor to provide sales and marketing services to domestic and international pharmaceutical companies seeking to emerge within the U.S. pharmaceutical market through the implementation of intelligent strategies focused on rapidly and rationally capturing market share. We achieve this on the basis of relationships, value-added services, and superior customer service, versus selling solely on price and/or sacrificing margins. Our focus is to treat each alliance product with importance, and to be able to infiltrate all classes of trade, leaving no opportunity unexplored. In addition, our goal is to collaborate and effectively communicate with partner organizations and to leverage our partner organization’s product(s) within our existing product portfolio.
We are interested in developing relationships and partnerships with Contract Manufacturers (CMO) that are (1) seeking a marketer for portfolio products, (2) pursuing an application for drug delivery technologies, or (3) implementing emerging manufacturing expertise.
We are enthusiastically open to partnering with pharmaceutical companies that desire to divest long-term brands that are (1) approaching the end of their life cycles, or (2) no longer being actively promoted.